A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms

A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms

Chemoresistance causes cancer relapse and metastasis, thus remaining the major obstacle to cancer therapy. While some light has been shed on the underlying mechanisms, it is clear that chemoresistance is a multifaceted problem strictly interconnected with the high heterogeneity of neoplastic cells....

Full description

Bibliographic Details
Main Authors: Laura Locatelli, Alessandra Cazzaniga, Giorgia Fedele, Monica Zocchi, Roberta Scrimieri, Claudia Moscheni, Sara Castiglioni, Jeanette A. Maier
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Current Issues in Molecular Biology
Subjects:
doxorubicin
LoVo cells
HL60 cells
TRPM7
MagT1
ROS
Online Access:https://www.mdpi.com/1467-3045/43/1/14

Internet

https://www.mdpi.com/1467-3045/43/1/14

Similar Items